4.6 Article

CARD9 Forms an Alternative CBM Complex in Richter Syndrome

Related references

Note: Only part of the references are listed.
Article Oncology

U-RT1-A new model for Richter transformation

Teresa Schmid et al.

Summary: The development of highly effective targeted therapies for chronic lymphocytic leukemia (CLL) has significantly changed the treatment landscape, but challenges remain in dealing with the transformation into aggressive B-cell lymphoma known as Richter syndrome (RS). The establishment of the U-RT1 cell line provides a suitable model system for investigating the pathogenesis of RS and exploring new treatment options.

NEOPLASIA (2021)

Article Hematology

B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation

Supriya Chakraborty et al.

Summary: BCR signals play a direct role in driving CLL cell proliferation by inducing both positive and negative regulators of the cell cycle. Genetic lesions that downregulate cell-cycle inhibitors like CDKN1A, CDKN2A, and CDKN2B, as well as TP53, lead to more aggressive disease and spontaneous proliferation. Furthermore, inactivating lesions in CDKN2A, CDKN2B, and TP53 frequently co-occur in Richter syndrome, and BCR stimulation with such lesions can induce proliferation.

BLOOD (2021)

Review Immunology

DAMP-sensing receptors in sterile inflammation and inflammatory diseases

Tao Gong et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Structures of autoinhibited and polymerized forms of CARD9 reveal mechanisms of CARD9 and CARD11 activation

Michael J. Holliday et al.

NATURE COMMUNICATIONS (2019)

Review Immunology

CARD-BCL-10-MALT1 signalling in protective and pathological immunity

Juergen Ruland et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Review Immunology

Dectin-1-Syk-CARD9 Signaling Pathway in TB immunity

Matthew Wagener et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease

Elizaveta S. Leshchiner et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Review Immunology

Innate cell communication kick-starts pathogen-specific immunity

Amariliz Rivera et al.

NATURE IMMUNOLOGY (2016)

Article Gastroenterology & Hepatology

BAY 11-7082, a nuclear factor-κB inhibitor, induces apoptosis and S phase arrest in gastric cancer cells

Ling Chen et al.

JOURNAL OF GASTROENTEROLOGY (2014)

Article Oncology

Risk Factors for Richter Syndrome in Chronic Lymphocytic Leukemia

Sameer A. Parikh et al.

CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2014)

Article Pathology

Plasmablastic Transformation of Low-grade B-cell Lymphomas Report on 6 Cases

Daniel Martinez et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)

Article Immunology

Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome

Giulia Fabbri et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2013)

Article Biochemistry & Molecular Biology

T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1

Jens Staal et al.

EMBO JOURNAL (2011)

Article Cell Biology

Antigen Receptor Signaling to NF-κB via CARMA1, BCL10, and MALT1

Margot Thome et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)

Review Oncology

Richter syndrome: molecular insights and clinical perspectives

Davide Ross et al.

HEMATOLOGICAL ONCOLOGY (2009)

Article Immunology

Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection

Matthew J. Robinson et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2009)

Article Multidisciplinary Sciences

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma

Georg Lenz et al.

SCIENCE (2008)

Article Hematology

Syk-dependent mTOR activation in follicular lymphoma cells

Ludivine Leseux et al.

BLOOD (2006)

Article Multidisciplinary Sciences

Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity

Olaf Gross et al.

NATURE (2006)

Review Oncology

Richter syndrome

AM Tsimberidou et al.

CANCER (2005)

Article Biochemistry & Molecular Biology

CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-κB

J Bertin et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)